Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|March 26, 2014
Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetesTesfaye Biftu, Ranabir Sinha-Roy, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2017
Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritisSobhana Babu Boga, Abdul-Basit Alhassan, Jian Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
Discovery of novel BTK inhibitors with carboxylic acidsXiaolei Gao, James Wang, Jian Liu, et al.
Bioorganic & Medicinal Chemistry|April 13, 2012
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerizationHarry R Chobanian, Yan Guo, Ping Liu, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid ArthritisJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chiralityPing Liu, Thomas J Lanza, Marc Chioda, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutesJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Pageof 3